Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

American Shared Hospital Services AMS

Healthcare  —  Medical Care Facilities
1.42 (0.04) (2.74%) as of 25 Sep
Market cap
$9.7M
P/E
0.0×
Dividend Champion (3y) Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

American Shared Hospital Services (AMS) Business Profile

Updated before January 2025

Company Overview

American Shared Hospital Services (AMS) is a leading provider of turnkey technology solutions for advanced medical treatments. Founded in 1980, AMS has been at the forefront of delivering innovative healthcare solutions to hospitals and medical centers across the United States and internationally. The company is headquartered in San Francisco, California, and is publicly traded on the NYSE American under the ticker symbol AMS.

AMS was established with the mission of improving access to cutting-edge medical technologies by offering flexible financing and operational models. The company’s leadership team, led by Chairman and CEO Ernest A. Bates, M.D., has decades of experience in the healthcare and medical technology sectors. Under their guidance, AMS has grown into a trusted partner for hospitals seeking to enhance their capabilities in radiation therapy and other advanced medical treatments.

Core Business Segments

AMS operates in several key business segments, focusing on providing advanced medical technologies and services. These include:

1. Radiation Therapy Services

AMS specializes in providing hospitals with access to state-of-the-art radiation therapy equipment, including linear accelerators and proton therapy systems. These technologies are critical for treating cancer patients and are often cost-prohibitive for hospitals to acquire independently. AMS offers flexible leasing and financing options, enabling healthcare providers to deliver high-quality care without the burden of upfront capital expenditures.

2. Proton Therapy Systems

Proton therapy is a cutting-edge cancer treatment that uses protons instead of X-rays to target tumors with precision, minimizing damage to surrounding healthy tissues. AMS is a pioneer in making proton therapy accessible to hospitals through its innovative business model. The company partners with healthcare providers to install and operate proton therapy centers, ensuring that patients have access to this advanced treatment option.

3. Gamma Knife Radiosurgery

AMS is a leading provider of Gamma Knife radiosurgery systems, which are used for non-invasive treatment of brain disorders, including tumors, vascular malformations, and functional disorders. The company’s Gamma Knife services include equipment leasing, installation, and ongoing maintenance, allowing hospitals to offer this specialized treatment without significant upfront investment.

4. Other Medical Equipment and Services

In addition to its core offerings, AMS provides a range of other medical technologies and services, including imaging equipment and consulting services. The company’s comprehensive approach ensures that hospitals have access to the tools and expertise they need to deliver exceptional patient care.

Business Model

AMS’s business model is centered on providing hospitals with access to advanced medical technologies through innovative financing and operational solutions. The company typically enters into long-term agreements with healthcare providers, offering equipment leasing, turnkey solutions, and shared-service arrangements. This approach allows hospitals to adopt cutting-edge technologies without the financial burden of purchasing equipment outright.

AMS generates revenue through a combination of equipment leasing fees, service contracts, and revenue-sharing agreements. By aligning its interests with those of its hospital partners, AMS ensures that both parties benefit from the successful implementation and operation of advanced medical technologies.

Strategic Direction

AMS is committed to expanding its portfolio of advanced medical technologies and services to meet the evolving needs of healthcare providers. The company’s strategic priorities include:

  • Service Growth: AMS aims to increase its market share in radiation therapy, proton therapy, and Gamma Knife radiosurgery by partnering with more hospitals and medical centers. The company is also exploring opportunities to expand its presence in international markets.
  • Sustainability Goals: AMS is focused on promoting sustainability in its operations and partnerships. This includes adopting energy-efficient technologies and minimizing the environmental impact of its equipment and services.
  • New Product Categories: AMS is actively exploring opportunities to diversify its offerings by investing in emerging medical technologies, such as artificial intelligence (AI)-driven diagnostic tools and advanced imaging systems.

Competitive Landscape

AMS operates in a competitive market, facing competition from both large multinational corporations and smaller specialized providers. Key competitors include:

  • Varian Medical Systems: A leading provider of radiation therapy and proton therapy equipment.
  • Elekta AB: A global company specializing in precision radiation therapy and radiosurgery solutions.
  • Accuray Incorporated: A provider of innovative radiation therapy systems, including the CyberKnife and TomoTherapy platforms.
  • Philips Healthcare and Siemens Healthineers: Major players in the broader medical technology market, offering a range of imaging and treatment solutions.

Despite the competitive landscape, AMS differentiates itself through its flexible business model, long-term partnerships, and focus on making advanced medical technologies accessible to hospitals of all sizes.

Risk Factors

Like any business, AMS faces several risks that could impact its operations and financial performance. Key risk factors include:

  • Market Dependence: AMS’s revenue is heavily dependent on the adoption of its radiation therapy and proton therapy solutions. Any decline in demand for these technologies could negatively affect the company’s financial performance.
  • Regulatory Challenges: The healthcare industry is subject to extensive regulation, and changes in laws or reimbursement policies could impact AMS’s business.
  • Supply Chain Disruptions: AMS relies on third-party manufacturers for its equipment. Any disruptions in the supply chain could delay the delivery of products and services to customers.
  • Technological Obsolescence: The rapid pace of technological innovation in the medical field means that AMS must continually invest in new technologies to remain competitive.

Recent Developments

AMS has recently made significant strides in expanding its offerings and enhancing its operational capabilities. Notable developments include:

  • Proton Therapy Expansion: AMS has partnered with several hospitals to establish new proton therapy centers, increasing access to this advanced cancer treatment.
  • Technology Upgrades: The company has invested in upgrading its existing equipment to incorporate the latest advancements in radiation therapy and radiosurgery.
  • International Growth: AMS has entered into agreements with healthcare providers in emerging markets, positioning itself for long-term growth in regions with increasing demand for advanced medical technologies.
  • Sustainability Initiatives: AMS has implemented measures to reduce its environmental footprint, including the adoption of energy-efficient equipment and sustainable business practices.

Investment Considerations

Investors considering AMS as a potential investment should weigh the company’s strengths and risks. Key considerations include:

Strengths

  • Established track record of providing advanced medical technologies.
  • Flexible business model that aligns with the needs of healthcare providers.
  • Strong leadership team with extensive industry experience.
  • Growing demand for radiation therapy and proton therapy solutions.

Risks

  • Dependence on a limited number of core products and services.
  • Exposure to regulatory and reimbursement risks.
  • Potential for supply chain disruptions and technological obsolescence.

Conclusion

American Shared Hospital Services is a trusted partner for hospitals seeking to enhance their capabilities in advanced medical treatments. With a strong focus on radiation therapy, proton therapy, and Gamma Knife radiosurgery, AMS is well-positioned to capitalize on the growing demand for these technologies. While the company faces challenges such as regulatory risks and market dependence, its innovative business model and commitment to sustainability provide a solid foundation for future growth. As AMS continues to expand its offerings and enter new markets, it remains a compelling option for investors seeking exposure to the healthcare technology sector.